// App-Quantinova.ai

222 : Efficacy of sarilumab in patients with rheumatoid arthritis who previously received sarilumab or tocilizumab

Researchers

Presenter

  • Paul Emery

Principal Investigators

  • Hubert van Hoogstraten

  • Shyamalie Jayawardena

  • Erin Mangan

  • Paula Cejas

  • Patrick Verschueren

Medical Centers

  • Medical Affairs, Sanofi, Bridgewater, NJ, USA

  • Biostatistics and Programming, Sanofi, Bridgewater, NJ, USA

  • Medical Analytics, Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA

  • Reumatología, Hospital Quirónsalud Infanta Luisa, Sevilla, SPAIN

  • Rheumatology, University Hospitals Leuven, Leuven, BELGIUM

Locations

  • United Kingdom

  • United States

  • Spain

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Tocilizumab

  • Sarilumab

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

Phase

  • NA

Study Id's

  • NCT01768572

  • NCT01146652

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved